Angiotensin-converting enzyme and enkephalinase in human breast cyst fluid

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 807-813

  Frame, K L ^a   Patton, K ^a   Reed, M J ^a   Ghilchik, M W ^b   Parish, D C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Angiotensin converting enzyme; Breast cyst fluid; Enkephalinase

Indexed keywords

BATROXOBIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; EDETIC ACID; IODINE 125; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE; METENKEPHALIN[6 ARGININE 7 PHENYLALANINE]; PEPTIDASE; PHOSPHORAMIDON; THIORPHAN;

ARTICLE; BREAST CYST; CYST FLUID; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SUBSTRATE; FEMALE; FLUOROMETRY; HUMAN; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0029782443     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.440     Document Type: Article

References (46)

1. ANGELI A, DOGLIOTTI L, NALDONI C, ORLANDI F, PULIGHEDDU B, CARACI P, BUCCHI L, TORTA M AND BRUZZI P. (1994). Steroid biochemistry and categorisation of breast cyst fluid: relation to breast cancer risk. J. Steroid Biochem. Mol. Biol., 49, 333-339.
2. AVIV R, GURBANOV K, HUFFMAN A, BLUMBERG S AND WINAVER J. (1995). Urinary neutral endopeptidase 24.11 activity: modulation by chronic salt loading. Kidney Intl., 47, 855-860.
3. BODIAN CA. (1990). Some limitations on studies about the relation between gross cystic disease and risk of subsequent breast cancer. Ann. NY Acad. Sci., 586, 259- 265.
4. BODIAN CA. (1993). Benign breast disease, carcinoma in situ and breast cancer risk. Epidemiol. Rev., 15, 177-187.
5. BUNDRED NJ, WEST RR, DOWD JO, MANSEL RE AND HUGHES LE. (1991). Is there an increased risk of breast cancer in women who have had a breast cyst aspirated? Br. J. Cancer, 64, 953 955.
6. CARACI P, NALDONI C, COSTANTINI M AND ANGELI A. (1994). Cationic categorisation of breast cyst fluid and breast cancer risk. Endocrine-Related Cancer, 2, 15-26.
7. CIATTO S, BIGGERI A, ROSSELI DEL TURCO M, BARTOLI D AND IOSSA A. (1990) Risk of breast cancer subsequent to proven gross cystic disease. Eur. J. Cancer, 26, 555-557.
8. DIXON JM, LUMSDEN AB AND MILLER WR. (1985). The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease. Eur. J. Cancer Clin. Oncol., 21, 1047-1050.
9. DUPONT WD AND PAGE DL. (1985). Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med., 312, 146-151.
10. DUPONT WD, PARL FF, HARTMANN WH, BRINTON LA. WINFIELD AC, WORRELL, JA, SCHUYLER PA AND PLUMMER WD. (1993). Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer, 71, 1258-1265.
11. FRAME K AND PARISH DC. (1992). Protease activity in breast cyst fluid, MCF-7 and T47D cells interferes in Met-Enkephalin Arg Phe assay. J. Endocrinol., 132, (Suppl.), 262.
12. FRIEDLAND J AND SILVERSTEIN E. (1976). A sensitive fluorometric assay for serum Angiotensin Converting Enzymc. Am. J. Clin. Pathol., 66, 416-424.
13. GANJU RK, SUNDAY M, TSARWHAS DG, CARD A AND SHIPP MA. (1994). CD10/NEP in non-small cell lung carcinomas. J. Clin. Invest., 94, 1784-1791.
14. GUSTERSON BA, MONAGHAN P, MAHENDRAN R, ELLIS J AND O'HARE MJ. (1986) Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic antigen antibody A12. J. Natl Cancer Inst., 77, 343-349.
15. HAAGENSEN CD. (1971). Disease of the Breast, 2nd edn. W.B. Saunders & Co.: Philadelphia.
16. HAMED H, WANG DY, MOORE JW, CLARK GMG AND FENTIMAN IS. (1990). Growth factor and electrolyte concentration in human breast cyst fluid. Eur. J. Cancer, 26, 479 480.
17. HAYAKARI M, SEITO R, FURUGORI A, HASHIMOTO Y AND MURAKAMI S. (1984). An improved colorimetric assay of angiotensin-converting enzyme in serum. Clin. Chim. Acta., 144, 71-75.
18. HOOPER NM. (1991). Angiotensin converting enzyme: implications from molecular biology for its physiological function. Int. J. Biochem., 23, 641-647.
19. KASE R, SEIKINE R, KATAYAMA T, TAKAGI H AND HAZATO T. (1986). Hydrolysis of neo-kyotorphin (Thr-Ser-Lys-Arg) and [Met]Enkephalin-Arg-Phe by angiotensin converting enzyme from monkey brain. Biochem. Pharmacol., 35, 4499-4503.
20. KATAYAMA M, NADEL JA, BUNNETT NW, DI MARIA GU, HAXHIU M AND BORSON DB. (1991) Catabolism of calcitonin gene-related peptide and substance P by neutral endopeptidase Peptides, 12, 563-567.
21. KENNY AJ. (1993). Endopeptidase 24.11: putative substrates and possible roles. Biochem. Soc. Trans., 21, 663-667.
22. KENNY AJ, O'HARE MJ AND GUSTERSON BA. (1989) Cell surface peptidases as modulators of growth and differentiation. Lancet, 2, 785-787.
23. KESNER L, YU W, BRADLOW HL, BREED CW AND FLEISHER M. (1988). Proteases in cyst fluid from human gross cyst disease. Cancer Res., 48, 6379-6383.
24. LAI LC, GHATEI MA, TAKAHASHI K, PATEL KV, SCHREY MP, GHILCHIK MW, BLOOM SR AND JAMES VHT. (1990a). Mitogenic peptides in breast cyst fluid: relationship with intracystic electrolyte ratio. Int. J. Cancer, 46, 1014-1016.
25. LAI LC, DUNKLEY SA, REED MJ, GHILCHIK MW, SHAIKH NA AND JAMES VHT. (1990b). Epidermal growth factor and oestradiol in human breast cyst fluid. Eur. J. Cancer, 26, 481-484.
26. LEIS HP. (1993). Gross Breast Cysts: significance of apocrine type, identification by cyst fluid analysis and management. Breast Disease, 6, 185-194.
27. MILLER WR, SCOTT WN, HARRIS WH AND WANG D. (1992). Using biological measurements, can patients with benign breast disease who are at high risk for breast cancer be identified. Cancer Detect. Prev., 16, 99-106.
28. NALDONI C, COSTANTINI M, DOGLIOTTI L, BRUZZI P, BUCCHI L, BUZZI G, TORTA M AND ANGELI A. (1992). Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast. Cancer Res., 52, 1791-1795.
29. NESS JC, SEDGHINASAB M, MOE RE AND TAPPER D. (1993). Identification of multiple proliferative growth factors in breast cyst fluid. Am. J. Surg., 166, 237-243.
30. ONDETTI MA, WILLIAMS NJ, SABO EF, PLUSCEC J, WEAVER ER AND KOCY O. (1971). Angiotensin-Converting Enzyme Inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure and synthesis. Biochemistry, 19, 4033-4039.
31. PAGE DL, VAN DER ZWAAG R, ROGERS LW, WILLIAMS LT, WALKER WE AND HARTMANN WH. (1978). Relation between component parts of fibrocystic disease complex and breast cancer. J. Natl Cancer Inst., 61, 1055-1063.
32. PARISH DC. (1994). The role of proteolysis in tumour invasion and growth. Endocrine-Related Cancer, 1, 19-36.
33. PEKONEN F, NYMAN T, ÄMMÄLÄ M AND RUTANEN E-M. (1995). Decreased expression of messenger RNAs encoding endothelin receptors and neutral endopeptidase 24.11 in endometrial cancer Br. J. Cancer, 71, 59-63.
34. REED MJ, ANGELI A, THIJSSEN JH, MILEWlCZ A, SZAMEL L, HUBER J, HARLOZINSKA-SZMYRKA A, TOTH J AND KORNAFEL J. (1994). Gross cystic breast disease: overview and directions for future research. Endocrine-Related Cancer, 2, 9-13.
35. SANCHEZ LM, VIZOSO F, ALLENDE MT, RUIBAL A AND LOPEZOTIN C. (1992). Quantification and molecular analysis of Cathepsin D in breast cyst fluids. Eur. J. Cancer, 28A, 828-832.
36. SCAMBIA G, PANICI PD, FERRANDINA G, BATTAGLIA F, ROSSI S, BELLANTONE R, CRUCITTI F AND MANCUSO S. (1991). Cathepsin D and epidermal growth factor in human breast cyst fluid. Br. J. Cancer, 64, 965-967.
37. SCHON HJ, SCHURZ B, WENZL R, KNOGLER W AND KUBISTA E. (1993). β-Endorphin, steroids and prolactin immunoassay in breast cysts and blood. Arch. Pathol. Lab. Med., 117, 248-253.
38. SCHREY MP AND PATEL KV. (1994). Role of regulatory peptides in the control of breast cancer cell growth and function. Endocrine-Related Cancer, 3, 41-70.
39. SCHURZ B, SCHON HJ, WENZL R, KUBISTA E, SPONA J, HUBA J AND WEINDLMAYR-GOETTEL M. (1991). Breast cyst fluid concentrations of beta-endorphin, steroids and gonadotrophins in premenopausal women with gross cystic disease. Maturitas, 13, 123-128.
40. SCHWEISFURTH H, SCHMIDT M, BRUGGER E, MAIWALD L AND THIEL H. (1985) Alterations of serum carboxypeptidases N and angiotensin-I converting enzyme in malignant diseases. Clin. Biochem., 18, 242-246.
41. SETHI T AND ROZENGURT E. (1991). Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin and neurotensin. Cancer Res., 51, 3621-3623.
42. SHIPP MA, VIJARAGHAVAN J, SCHMIDT E, MASTELLER EL, D'ADAMIOL, HERSH LB AND REINHERZ ELA. (1989). Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ('enkephalinase'): direct evidence by cDNA transfection analysis. Proc. Natl Acad. Sci USA, 86, 297-301.
43. SHIPP MA, TARR GE, CHENN C-Y, SWITZER SN, HERSCH LB, STEIN H, SUNDAY ME AND REINHERZ EL. (1991). CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinoma of the lung. Proc. Natl Acad. Sci. USA, 88, 10662-10666.
44. SPILLANTINI MG, SICUTERI F, SALMON S AND MALFROY B. (1990). Characterisation of Endopeptidase 3.4.24.11 (Enkephalinase) activity in human plasma and cerebrospinal fluid. Biochem. Pharmacol., 39, 1353-1356.
45. VARELA SA AND SAEZ JJBL. (1993). Utility of serum activity of angiotensin-converting enzyme as a tumour marker. Oncology, 50, 430-435.
46. WEBER CJ, O'DORISIO TM, HOWE B, KOSCHITZKY T AND MERRIAM L. (1989). Gastrin releasing peptide-, calcitonin generelated peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin releasing peptide-like immunoreactivity in human breast carcinoma cell lines. Surgery, 106, 1134-1140.